CHARLOTTE, N.C. — November 25, 2025 — Leads & Copy — Prenetics Global Limited (NASDAQ: PRE) announced its participation in two upcoming investor conferences.
The health sciences company, and parent of the IM8 premium health and longevity brand, will participate in The Benchmark Company’s 14th Annual Discovery One-on-One Conference on December 4, 2025, at the New York Athletic Club in New York City. Prenetics Chief Executive Officer Danny Yeung will be available for one-on-one meetings with investors during the conference.
Prenetics will also participate in Sidoti’s Year End Virtual Investor Conference, being held December 10-11, 2025. Danny Yeung will deliver a formal presentation at 10:00a.m. Eastern Time on Wednesday, December 10, 2025. The presentation will be available here. Chief Financial Officer Stephen Lo will accompany Yeung for one-on-one meetings with investors throughout the conference. A replay of the Sidoti presentation webcast will be available on the company’s investor relations website following the event.
Individuals interested in scheduling a one-on-one meeting with Prenetics management can contact Investor Relations at PRE@mzgroup.us or their Benchmark or Sidoti representatives.
Prenetics is a health sciences company redefining the future of health and longevity through IM8, its consumer brand co-founded with David Beckham and championed by tennis player Aryna Sabalenka. IM8 achieved the fastest growth trajectory in the supplement industry history, reaching $108 million in ARR within 12 months of launch, outpacing leading AI startups.
Prenetics is also the first consumer health company to establish a Bitcoin Treasury, purchasing 1 Bitcoin per day, now totaling 501 BTC as of November 24, 2025.
IM8 is a subsidiary of Prenetics and delivers a holistic, science-backed approach to health. IM8’s flagship product, Daily Ultimate Essentials, is an all-in-one powder supplement engineered to replace 16 different supplements in a drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. To learn more, visit www.IM8health.com.
Investor Relations Contacts:
investors@prenetics.com
PRE@mzgroup.us
Source: Prenetics Global Limited
Source: Prenetics Global Limited
